Literature DB >> 31484487

Gallbladder cancer: epidemiology and genetic risk associations.

Mikayla A Schmidt1, Lorena Marcano-Bonilla2, Lewis R Roberts3.   

Abstract

Gallbladder cancer (GBC) is a form of hepatobiliary malignancy that develops from the mucosal lining of the gallbladder. The early development of gallbladder cancer is usually asymptomatic and gallbladder cancer has a high propensity to metastatic dissemination, thus most patients are diagnosed at intermediate to advanced stages for which there is no curative treatment. Consequently, gallbladder cancer is highly lethal. Though the overall global incidence of gallbladder cancer is low, there is marked geographic variation and ethnic communities in Asia as well as Native American populations in both North and South America are affected disproportionately. This article provides a comprehensive overview of the current epidemiology and risk and protective factors associated with gallbladder cancer development. In addition, the current knowledge on environmental and genetic risk associations for gallbladder cancer and the need for additional large-scale genome wide association studies (GWAS) are discussed.

Entities:  

Keywords:  Gallbladder cancer (GBC); epidemiology; gallbladder neoplasms; genetic predisposition to disease; molecular genetics

Mesh:

Year:  2019        PMID: 31484487     DOI: 10.21037/cco.2019.08.13

Source DB:  PubMed          Journal:  Chin Clin Oncol        ISSN: 2304-3865


  23 in total

1.  Comment on: development and external validation of a model to predict overall survival in patients with resected gallbladder cancer.

Authors:  Sakti Chakrabarti; Amit Mahipal
Journal:  Hepatobiliary Surg Nutr       Date:  2022-02       Impact factor: 7.293

2.  Novel protein kinase inhibitor TT-00420 inhibits gallbladder cancer by inhibiting JNK/JUN-mediated signaling pathway.

Authors:  Huijie Miao; Yajun Geng; Yang Li; Shijie Tang; Feiling Feng; Weijian Li; Yongsheng Li; Liguo Liu; Rui Zhang; Shimei Qiu; Ying Wu; Zeyu Wang; Ziyi Wang; Ziyu Shao; Ke Liu; Lu Zou; Mao Yang; Yuhao Zhao; Chen Chen; Zhizhen Li; Dadong Zhang; Peng Peng; Xiaoyan Qiang; Frank Wu; Yongning He; Luonan Chen; Dongxi Xiang; Xiaoqing Jiang; Maolan Li; Yun Liu; Yingbin Liu
Journal:  Cell Oncol (Dordr)       Date:  2022-07-23       Impact factor: 7.051

Review 3.  The role of PI3K/AKT signaling pathway in gallbladder carcinoma.

Authors:  Zeyu Wu; Xiao Yu; Shuijun Zhang; Yuting He; Wenzhi Guo
Journal:  Am J Transl Res       Date:  2022-07-15       Impact factor: 3.940

4.  Aetiology of Obstructive Jaundice in Ghana: A Retrospective Analysis in a Tertiary Hospital.

Authors:  Offei K Asare; Fred Osei; Andrea A Y Appau; Benjamin D Sarkodie; Kenneth Tachi; Adwoa A Nkansah; Timothy Acheampong; Christopher Nwaokweanwe; David Olayiwola
Journal:  J West Afr Coll Surg       Date:  2022-05-04

5.  Aspirin, Statins, Non-aspirin NSAIDs, Metformin, and the Risk of Biliary Cancer: A Swedish Population-Based Cohort Study.

Authors:  Lewis R Roberts; Nele Brusselaers; Lorena Marcano-Bonilla; Cathy D Schleck; William S Harmsen; Omid Sadr-Azodi; Mitesh J Borad; Tushar Patel; Gloria M Petersen; Terry M Therneau
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2022-04-01       Impact factor: 4.090

6.  Comparison of Prediction Models for Acute Kidney Injury Among Patients with Hepatobiliary Malignancies Based on XGBoost and LASSO-Logistic Algorithms.

Authors:  Yunlu Zhang; Yimei Wang; Jiarui Xu; Bowen Zhu; Xiaohong Chen; Xiaoqiang Ding; Yang Li
Journal:  Int J Gen Med       Date:  2021-04-16

Review 7.  Gallbladder cancer revisited: the evolving role of a radiologist.

Authors:  Anupama Ramachandran; Deep Narayan Srivastava; Kumble Seetharama Madhusudhan
Journal:  Br J Radiol       Date:  2020-10-23       Impact factor: 3.039

8.  Upregulation of PAIP1 promotes the gallbladder tumorigenesis through regulating PLK1 level.

Authors:  Jianping Bi; Hong Ma; Yafei Liu; Ai Huang; Yong Xiao; Wen-Jie Shu; Haining Du; Tao Zhang
Journal:  Ann Transl Med       Date:  2021-06

9.  Incidence and Mortality of Cancers of the Biliary Tract, Gallbladder, and Liver by Sex, Age, Race/Ethnicity, and Stage at Diagnosis: United States, 2013 to 2017.

Authors:  Taylor D Ellington; Behnoosh Momin; Reda J Wilson; S Jane Henley; Manxia Wu; A Blythe Ryerson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-07-08       Impact factor: 4.090

10.  Identification of Altered Genes in Gallbladder Cancer as Potential Driver Mutations for Diagnostic and Prognostic Purposes: A Computational Approach.

Authors:  Vívian D'Afonseca; Ariel D Arencibia; Alex Echeverría-Vega; Leslie Cerpa; Juan P Cayún; Nelson M Varela; Marcela Salazar; Luis A Quiñones
Journal:  Cancer Inform       Date:  2020-05-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.